全体要約
豚繁殖・呼吸器症候群（PRRS）ワクチン市場は、2023年に数百万米ドルの価値が推定され、2030年までに同様の規模に調整される見込みです。2024年から2030年の予測期間中、年平均成長率（CAGR）は%とされています。PRRSに対する認識の高まりや、動物ケア支出の増加、獣医生物製剤分野での研究開発活動が市場成長を促進しています。ワクチン接種された豚は、野生型ウイルスの伝播頻度を大幅に減少させ、危険な病気の予防に寄与します。
市場は、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカの地域に分かれ、主要企業にはメルク、ヒプラ、シノファーム動物健康、セバ・サンテ・アニマル、ボエリンガーインゲルハイムなどがあります。市場セグメントは、タイプ別（CH-1R株、PC株など）および用途別（雌豚、母豚など）に分析され、各地域の市場規模と発展可能性が評価されています。政府の投資増加も、獣医自家製ワクチンの需要を高める要因とされています。
関連する質問
Merck, HIPRA, Sinopharm Animal Health Co., Ltd, Ceva Santé Animale, CAVAC, Bioveta, Jinyu Bio-Technology, Zoetis, Boehringer Ingelheim, Harbin Pharmaceutical Group
PRRSに関する意識の高まり, 獣医生物製剤分野におけるR&D活動の増加, 政府の投資の増加
概要
世界のPIG豚生殖および呼吸器症候群（PRRS）ワクチン市場は、2023年にXX米ドルの価値が見積もられ、2030年までに再調整された規模はXX米ドルになると予測されています。予測期間2024年から2030年の間にCAGRはXX%です。
PRRSに対する意識の高まりが市場の成長を促進しています。市場のもう一つの機会は、動物ケア支出の増加と獣医バイオロジクス分野の研究開発活動の増加です。ワクチン接種された豚は、野生型ウイルスの感染頻度を大幅に減少させ、危険な病気の予防に寄与すると期待されています。さらに、政府の投資の増加も、予測期間中に獣医用自己ワクチンへの世界的な需要を高めると予想されています。しかし、研究開発コストは市場の成長を妨げる可能性があります。
報告の範囲
このレポートは、PIG豚繁殖・呼吸症候群（PRRS）ワクチンの世界市場に関する包括的なプレゼンテーションを提供することを目的としており、総販売量、販売収益、価格、主要企業の市場シェアとランキング、さらに地域別・国別、タイプ別、用途別のPIG豚繁殖・呼吸症候群（PRRS）ワクチンの分析が含まれています。
PIG豚の生殖および呼吸器症候群（PRRS）ワクチン市場の規模、推定、予測は、2023年を基準年とし、2019年から2030年までの期間における販売数量（Kユニット）および販売収益（百万ドル）で提供されます。定量分析と定性分析の両方を用いて、読者が事業/成長戦略を策定し、市場競争状況を評価し、現在の市場における自らの位置を分析し、PIG豚の生殖および呼吸器症候群（PRRS）ワクチンに関して情報に基づいたビジネス判断を行えるよう支援します。
市場セグメンテーション
会社別
メルク
ヒプラ
シノファームアニマルヘルス株式会社
セヴァ・サンテ・アニマル
カヴァック
ビオヴェタ
ジンユーバイオテクノロジー
ゾエティス
バイエル薬品
ハルビン製薬グループ
タイプ別セグメント:
CH-1R歪み
PCストレイン
その他
アプリケーション別セグメント
ギルト
雌豚
地域別
北米
アメリカ合衆国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋
中国
日本
韓国
中国 台湾
東南アジア
インド
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中東およびアフリカ
トルコ
サウジアラビア
UAE（アラブ首長国連邦）
章の概要
第1章：報告の範囲、世界全体の市場規模（バルブ、量値、価格）を紹介します。この章では、市場の動向、市場の最新の発展、市場の推進要因と制約要因、業界のメーカーが直面する課題やリスク、業界関連政策の分析も提供します。
第2章：PIGポルシン生殖呼吸症候群（PRRS）ワクチンメーカーの競争状況、価格、販売及び収益の市場シェア、最新の開発計画、合併及び買収情報などの詳細分析です。
第3章：各市場セグメントのタイプ別分析を提供し、市場規模と各市場セグメントの開発可能性をカバーします。これにより、読者は異なる市場セグメントにおけるブルーオーシャン市場を見つける手助けとなります。
第4章：アプリケーション別のさまざまな市場セグメントの分析を提供し、それぞれの市場セグメントの市場規模と成長の可能性をカバーしており、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。
第5章：地域レベルにおける豚生殖呼吸器症候群（PRRS）ワクチンの売上と収益です。各地域の市場規模と発展可能性について定量的な分析を提供し、世界各国の市場の発展、将来の発展の見通し、市場の余地、そして市場規模を紹介します。
第6章：国別のPIG豚繁殖・呼吸器症候群（PRRS）ワクチンの販売と収益。国/地域ごとのタイプおよびアプリケーション別のシグマテデータを提供します。
第7章：主要企業の基本状況を詳細に紹介するため、重要なプレイヤーのプロフィールを提供し、製品の販売、収益、価格、粗利益、製品の導入、最近の開発などを含みます。
第8章：産業チェーンの分析、業界の上流と下流を含む。
第9章: 結論。
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 市場概要
1.1 豚繁殖・呼吸器症候群（PRRS）ワクチン : プロダクトのイントロダクション
1.2 グローバルの市場規模、市場予測
1.2.1 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチン売上規模、金額ベース（2019年～2030年）
1.2.2 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチン売上規模、数量ベース（2019年～2030年）
1.2.3 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチン市場、販売価格動向（2019年～2030年）
1.3 豚繁殖・呼吸器症候群（PRRS）ワクチン市場トレンドと成長ドライバー
1.3.1 豚繁殖・呼吸器症候群（PRRS）ワクチン業界トレンド
1.3.2 豚繁殖・呼吸器症候群（PRRS）ワクチン市場のドライバーと事業機会
1.3.3 豚繁殖・呼吸器症候群（PRRS）ワクチン市場の課題
1.3.4 豚繁殖・呼吸器症候群（PRRS）ワクチン市場の抑制要因
1.4 前提条件と限界
1.5 調査の目的
1.6 対象年
2 競合分析、企業別
2.1 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチン、プレイヤー収益ランキング（2023年）
2.2 グローバルにおける豚繁殖・呼吸器症候群（PRRS）ワクチン市場の収益規模、企業別（2019年～2024年）
2.3 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチン、プレイヤー売上数量ランキング（2023年）
2.4 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチン、売上数量（企業別）（2019年～2024年）
2.5 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチンの平均価格、企業別（2019年～2024年）
2.6 豚繁殖・呼吸器症候群（PRRS）ワクチンの主要メーカー、製造・販売拠点およびヘッドクオーター
2.7 豚繁殖・呼吸器症候群（PRRS）ワクチンの主要メーカー、製品展開
2.8 豚繁殖・呼吸器症候群（PRRS）ワクチンの主要メーカー、量産開始時期
2.9 豚繁殖・呼吸器症候群（PRRS）ワクチン市場の競争状況分析
2.9.1 豚繁殖・呼吸器症候群（PRRS）ワクチン市場集中度比率（2019年～2024年）
2.9.2 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチン、上位メーカー5～10社の収益（2023年）
2.9.3 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチン、企業タイプ別上位メーカー（Tier 1、Tier 2、Tier 3）、2023年の収益ベース
2.10 M&A、拡大
3 セグメンテーション、タイプ別
3.1 イントロダクション、タイプ別
3.1.1
3.1.2
3.1.3 その他
3.2 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチンの売上規模、金額ベース、タイプ別
3.2.1 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチンの売上規模、金額ベース、タイプ別（2019年、2023年、2030年）
3.2.2 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチンの売上規模、金額ベース、タイプ別（2019年～2030年）
3.2.3 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチンの売上規模、金額ベース、タイプ別（%）（2019年～2030年）
3.3 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチンの売上規模、数量ベース、タイプ別
3.3.1 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチンの売上規模、数量ベース、タイプ別（2019年、2023年、2030年）
3.3.2 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチンの売上規模、数量ベース、タイプ別（2019年～2030年）
3.3.3 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチンの売上規模、数量ベース、タイプ別（%）（2019年～2030年）
3.4 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチンの平均価格、タイプ別（2019年～2030年）
4 セグメンテーション、用途別
4.1 イントロダクション、用途別
4.1.1 ギルト
4.1.2 雌豚
4.2 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチンの売上規模、金額ベース、用途別
4.2.1 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチンの売上規模、金額ベース、用途別（2019年、2023年、2030年）
4.2.2 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチンの売上規模、金額ベース、用途別（2019年～2030年）
4.2.3 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチンの売上規模、金額ベース、用途別（%）（2019年～2030年）
4.3 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチンの売上規模、数量ベース、用途別
4.3.1 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチンの売上規模、数量ベース、用途別（2019年、2023年、2030年）
4.3.2 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチンの売上規模、数量ベース、用途別（2019年～2030年）
4.3.3 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチンの売上規模、数量ベース、用途別（%）（2019年～2030年）
4.4 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチンの平均価格、用途別（2019年～2030年）
5 セグメンテーション、地域別
5.1 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチンの売上規模、金額ベース、地域別
5.2 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチンの売上規模、数量ベース、地域別
5.3 グローバルの豚繁殖・呼吸器症候群（PRRS）ワクチンの平均価格、地域別（2019年～2030年）
5.4 北米
5.4.1 北米の豚繁殖・呼吸器症候群（PRRS）ワクチン売上規模、金額ベース、2019年～2030年
5.4.2 北米の豚繁殖・呼吸器症候群（PRRS）ワクチンの売上規模、金額ベース、国別（%）、2023年、2030年
5.5 ヨーロッパ
5.5.1 ヨーロッパの豚繁殖・呼吸器症候群（PRRS）ワクチン売上規模、金額ベース、2019年～2030年
5.5.2 ヨーロッパの豚繁殖・呼吸器症候群（PRRS）ワクチンの売上規模、金額ベース、国別（%）、2023年、2030年
5.6 アジア太平洋
5.6.1 アジア太平洋の豚繁殖・呼吸器症候群（PRRS）ワクチン売上規模、金額ベース、2019年～2030年
5.6.2 アジア太平洋の豚繁殖・呼吸器症候群（PRRS）ワクチンの売上規模、金額ベース、国別（%）、2023年、2030年
5.7 南米
5.7.1 南米の豚繁殖・呼吸器症候群（PRRS）ワクチン売上規模、金額ベース、2019年～2030年
5.7.2 南米の豚繁殖・呼吸器症候群（PRRS）ワクチンの売上規模、金額ベース、国別（%）、2023年、2030年
5.8 中東・アフリカ
5.8.1 中東・アフリカの豚繁殖・呼吸器症候群（PRRS）ワクチン売上規模、金額ベース、2019年～2030年
5.8.2 中東・アフリカの豚繁殖・呼吸器症候群（PRRS）ワクチンの売上規模、金額ベース、国別（%）、2023年、2030年
6 主要国・地域によるセグメンテーション
6.1 主要国・地域の豚繁殖・呼吸器症候群（PRRS）ワクチンの売上成長トレンド、金額ベース（2019年、2023年、2030年）
6.2 主要国・地域の豚繁殖・呼吸器症候群（PRRS）ワクチンの売上、金額ベース
6.3 米国
6.4 ヨーロッパ
6.5 中国
6.6 日本
6.7 韓国
6.8 東南アジア
6.9 インド
7 企業プロファイル
7.1 Merck
7.1.1 Merck：企業情報
7.1.2 Merckの紹介と事業概要
7.1.3 Merck：豚繁殖・呼吸器症候群（PRRS）ワクチンの売上、収益および売上総利益率（2019年〜2024年）
7.1.4 Merck：豚繁殖・呼吸器症候群（PRRS）ワクチン分野の提供製品
7.1.5 Merck直近の動向
7.2 HIPRA
7.2.1 HIPRA：企業情報
7.2.2 HIPRAの紹介と事業概要
7.2.3 HIPRA：豚繁殖・呼吸器症候群（PRRS）ワクチンの売上、収益および売上総利益率（2019年〜2024年）
7.2.4 HIPRA：豚繁殖・呼吸器症候群（PRRS）ワクチン分野の提供製品
7.2.5 HIPRA直近の動向
7.3 Sinopharm Animal Health Co\., Ltd
7.3.1 Sinopharm Animal Health Co\., Ltd：企業情報
7.3.2 Sinopharm Animal Health Co\., Ltdの紹介と事業概要
7.3.3 Sinopharm Animal Health Co\., Ltd：豚繁殖・呼吸器症候群（PRRS）ワクチンの売上、収益および売上総利益率（2019年〜2024年）
7.3.4 Sinopharm Animal Health Co\., Ltd：豚繁殖・呼吸器症候群（PRRS）ワクチン分野の提供製品
7.3.5 Sinopharm Animal Health Co\., Ltd直近の動向
7.4 Ceva Santé Animale
7.4.1 Ceva Santé Animale：企業情報
7.4.2 Ceva Santé Animaleの紹介と事業概要
7.4.3 Ceva Santé Animale：豚繁殖・呼吸器症候群（PRRS）ワクチンの売上、収益および売上総利益率（2019年〜2024年）
7.4.4 Ceva Santé Animale：豚繁殖・呼吸器症候群（PRRS）ワクチン分野の提供製品
7.4.5 Ceva Santé Animale直近の動向
7.5 CAVAC
7.5.1 CAVAC：企業情報
7.5.2 CAVACの紹介と事業概要
7.5.3 CAVAC：豚繁殖・呼吸器症候群（PRRS）ワクチンの売上、収益および売上総利益率（2019年〜2024年）
7.5.4 CAVAC：豚繁殖・呼吸器症候群（PRRS）ワクチン分野の提供製品
7.5.5 CAVAC直近の動向
7.6 Bioveta
7.6.1 Bioveta：企業情報
7.6.2 Biovetaの紹介と事業概要
7.6.3 Bioveta：豚繁殖・呼吸器症候群（PRRS）ワクチンの売上、収益および売上総利益率（2019年〜2024年）
7.6.4 Bioveta：豚繁殖・呼吸器症候群（PRRS）ワクチン分野の提供製品
7.6.5 Bioveta直近の動向
7.7 Jinyu Bio-Technology
7.7.1 Jinyu Bio-Technology：企業情報
7.7.2 Jinyu Bio-Technologyの紹介と事業概要
7.7.3 Jinyu Bio-Technology：豚繁殖・呼吸器症候群（PRRS）ワクチンの売上、収益および売上総利益率（2019年〜2024年）
7.7.4 Jinyu Bio-Technology：豚繁殖・呼吸器症候群（PRRS）ワクチン分野の提供製品
7.7.5 Jinyu Bio-Technology直近の動向
7.8 Zoetis
7.8.1 Zoetis：企業情報
7.8.2 Zoetisの紹介と事業概要
7.8.3 Zoetis：豚繁殖・呼吸器症候群（PRRS）ワクチンの売上、収益および売上総利益率（2019年〜2024年）
7.8.4 Zoetis：豚繁殖・呼吸器症候群（PRRS）ワクチン分野の提供製品
7.8.5 Zoetis直近の動向
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim：企業情報
7.9.2 Boehringer Ingelheimの紹介と事業概要
7.9.3 Boehringer Ingelheim：豚繁殖・呼吸器症候群（PRRS）ワクチンの売上、収益および売上総利益率（2019年〜2024年）
7.9.4 Boehringer Ingelheim：豚繁殖・呼吸器症候群（PRRS）ワクチン分野の提供製品
7.9.5 Boehringer Ingelheim直近の動向
7.10 Harbin Pharmaceutical Group
7.10.1 Harbin Pharmaceutical Group：企業情報
7.10.2 Harbin Pharmaceutical Groupの紹介と事業概要
7.10.3 Harbin Pharmaceutical Group：豚繁殖・呼吸器症候群（PRRS）ワクチンの売上、収益および売上総利益率（2019年〜2024年）
7.10.4 Harbin Pharmaceutical Group：豚繁殖・呼吸器症候群（PRRS）ワクチン分野の提供製品
7.10.5 Harbin Pharmaceutical Group直近の動向
8 業界チェーン分析
8.1 豚繁殖・呼吸器症候群（PRRS）ワクチン業界バリューチェーン
8.2 豚繁殖・呼吸器症候群（PRRS）ワクチン市場の上流分析
8.2.1 主要原材料
8.2.2 原材料と主要サプライヤー
8.2.3 製造コスト構造
8.3 中流分析
8.4 下流分析（顧客についての分析）
8.5 営業販売モデル、販売チャネル
8.5.1 豚繁殖・呼吸器症候群（PRRS）ワクチン 営業販売モデル
8.5.2 販売チャネル
8.5.3 豚繁殖・呼吸器症候群（PRRS）ワクチンの流通業者
9 調査の結果・結論
10 付録
10.1 調査手法
10.1.1 調査手法 / 調査アプローチ
10.1.2 データソース
10.2 執筆者の詳細
10.3 免責事項
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
The global market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Rising awareness about PRRS is driving the growth of the market. Another opportunity for the market includes increasing animal care spending and R&D activities in the veterinary biologics segment. Vaccinated pigs are expected to significantly reduce the frequency of wild-type virus transmission, helping to prevent dangerous diseases. Additionally, rising government investment is also expected to boost global demand for veterinary autologous vaccines during the forecast period. However, R&D costs may hinder the growth of the market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by region & country, by Type, and by Application.
The PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine.
Market Segmentation
By Company
Merck
HIPRA
Sinopharm Animal Health Co., Ltd
Ceva Santé Animale
CAVAC
Bioveta
Jinyu Bio-Technology
Zoetis
Boehringer Ingelheim
Harbin Pharmaceutical Group
Segment by Type:
CH-1R Strain
PC Strain
Others
Segment by Application
Gilts
Sows
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Introduction
1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Forecast
1.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value (2019-2030)
1.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume (2019-2030)
1.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price (2019-2030)
1.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Trends & Drivers
1.3.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends
1.3.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Drivers & Opportunity
1.3.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Challenges
1.3.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players Revenue Ranking (2023)
2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Company (2019-2024)
2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players Sales Volume Ranking (2023)
2.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Company Players (2019-2024)
2.5 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Company (2019-2024)
2.6 Key Manufacturers PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
2.9 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Competitive Analysis
2.9.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 CH-1R Strain
3.1.2 PC Strain
3.1.3 Others
3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type
3.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, by Type (2019-2030)
3.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, by Type (%) (2019-2030)
3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Type
3.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume, by Type (2019-2030)
3.3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume, by Type (%) (2019-2030)
3.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Gilts
4.1.2 Sows
4.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application
4.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, by Application (2019-2030)
4.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, by Application (%) (2019-2030)
4.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Application
4.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume, by Application (2019-2030)
4.3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume, by Application (%) (2019-2030)
4.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Region
5.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Region (2019-2024)
5.1.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Region (2025-2030)
5.1.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Region (%), (2019-2030)
5.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Region
5.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Region (2019-2024)
5.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Region (2025-2030)
5.2.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Region (%), (2019-2030)
5.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, 2019-2030
5.4.2 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, 2019-2030
5.5.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, 2019-2030
5.6.2 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, 2019-2030
5.7.2 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, 2019-2030
5.8.2 Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value
6.2.1 Key Countries/Regions PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, 2019-2030
6.2.2 Key Countries/Regions PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, 2019-2030
6.3.2 United States PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, 2019-2030
6.4.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, 2019-2030
6.5.2 China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type (%), 2023 VS 2030
6.5.3 China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, 2019-2030
6.6.2 Japan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, 2019-2030
6.7.2 South Korea PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, 2019-2030
6.8.2 Southeast Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, 2019-2030
6.9.2 India PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type (%), 2023 VS 2030
6.9.3 India PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Introduction and Business Overview
7.1.3 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Offerings
7.1.5 Merck Recent Development
7.2 HIPRA
7.2.1 HIPRA Company Information
7.2.2 HIPRA Introduction and Business Overview
7.2.3 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Offerings
7.2.5 HIPRA Recent Development
7.3 Sinopharm Animal Health Co., Ltd
7.3.1 Sinopharm Animal Health Co., Ltd Company Information
7.3.2 Sinopharm Animal Health Co., Ltd Introduction and Business Overview
7.3.3 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Offerings
7.3.5 Sinopharm Animal Health Co., Ltd Recent Development
7.4 Ceva Santé Animale
7.4.1 Ceva Santé Animale Company Information
7.4.2 Ceva Santé Animale Introduction and Business Overview
7.4.3 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Offerings
7.4.5 Ceva Santé Animale Recent Development
7.5 CAVAC
7.5.1 CAVAC Company Information
7.5.2 CAVAC Introduction and Business Overview
7.5.3 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Offerings
7.5.5 CAVAC Recent Development
7.6 Bioveta
7.6.1 Bioveta Company Information
7.6.2 Bioveta Introduction and Business Overview
7.6.3 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Offerings
7.6.5 Bioveta Recent Development
7.7 Jinyu Bio-Technology
7.7.1 Jinyu Bio-Technology Company Information
7.7.2 Jinyu Bio-Technology Introduction and Business Overview
7.7.3 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Offerings
7.7.5 Jinyu Bio-Technology Recent Development
7.8 Zoetis
7.8.1 Zoetis Company Information
7.8.2 Zoetis Introduction and Business Overview
7.8.3 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Offerings
7.8.5 Zoetis Recent Development
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Company Information
7.9.2 Boehringer Ingelheim Introduction and Business Overview
7.9.3 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Offerings
7.9.5 Boehringer Ingelheim Recent Development
7.10 Harbin Pharmaceutical Group
7.10.1 Harbin Pharmaceutical Group Company Information
7.10.2 Harbin Pharmaceutical Group Introduction and Business Overview
7.10.3 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Offerings
7.10.5 Harbin Pharmaceutical Group Recent Development
8 Industry Chain Analysis
8.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industrial Chain
8.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Model
8.5.2 Sales Channel
8.5.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables Table 1. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Trends Table 2. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Drivers & Opportunity Table 3. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Challenges Table 4. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Restraints Table 5. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Company (2019-2024) & (US$ Million) Table 6. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Company (2019-2024) Table 7. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Company (2019-2024) & (K Units) Table 8. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume Market Share by Company (2019-2024) Table 9. Global Market PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Company (2019-2024) & (US$/Unit) Table 10. Key Manufacturers PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Base Distribution and Headquarters Table 11. Key Manufacturers PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Type Table 12. Key Manufacturers Time to Begin Mass Production of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Table 13. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine as of 2023) Table 15. Mergers & Acquisitions, Expansion Plans Table 16. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million) Table 17. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type (2019-2024) & (US$ Million) Table 18. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type (2025-2030) & (US$ Million) Table 19. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Type (2019-2024) & (%) Table 20. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Type (2025-2030) & (%) Table 21. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units) Table 22. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Type (2019-2024) & (K Units) Table 23. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Type (2025-2030) & (K Units) Table 24. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Type (2019-2024) & (%) Table 25. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Type (2025-2030) & (%) Table 26. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2019-2024) & (US$/Unit) Table 27. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2025-2030) & (US$/Unit) Table 28. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million) Table 29. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application (2019-2024) & (US$ Million) Table 30. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application (2025-2030) & (US$ Million) Table 31. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Application (2019-2024) & (%) Table 32. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Application (2025-2030) & (%) Table 33. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units) Table 34. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Application (2019-2024) & (K Units) Table 35. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Application (2025-2030) & (K Units) Table 36. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Application (2019-2024) & (%) Table 37. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Application (2025-2030) & (%) Table 38. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2019-2024) & (US$/Unit) Table 39. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2025-2030) & (US$/Unit) Table 40. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million) Table 41. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Region (2019-2024) & (US$ Million) Table 42. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Region (2025-2030) & (US$ Million) Table 43. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Region (2019-2024) & (%) Table 44. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Region (2025-2030) & (%) Table 45. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030 Table 46. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Region (2019-2024) & (K Units) Table 47. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Region (2025-2030) & (K Units) Table 48. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Region (2019-2024) & (%) Table 49. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Region (2025-2030) & (%) Table 50. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Region (2019-2024) & (US$/Unit) Table 51. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Region (2025-2030) & (US$/Unit) Table 52. Key Countries/Regions PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030 Table 53. Key Countries/Regions PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, (2019-2024) & (US$ Million) Table 54. Key Countries/Regions PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, (2025-2030) & (US$ Million) Table 55. Key Countries/Regions PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume, (2019-2024) & (K Units) Table 56. Key Countries/Regions PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume, (2025-2030) & (K Units) Table 57. Merck Company Information Table 58. Merck Introduction and Business Overview Table 59. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 60. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Offerings Table 61. Merck Recent Development Table 62. HIPRA Company Information Table 63. HIPRA Introduction and Business Overview Table 64. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 65. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Offerings Table 66. HIPRA Recent Development Table 67. Sinopharm Animal Health Co., Ltd Company Information Table 68. Sinopharm Animal Health Co., Ltd Introduction and Business Overview Table 69. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 70. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Offerings Table 71. Sinopharm Animal Health Co., Ltd Recent Development Table 72. Ceva Santé Animale Company Information Table 73. Ceva Santé Animale Introduction and Business Overview Table 74. Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 75. Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Offerings Table 76. Ceva Santé Animale Recent Development Table 77. CAVAC Company Information Table 78. CAVAC Introduction and Business Overview Table 79. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 80. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Offerings Table 81. CAVAC Recent Development Table 82. Bioveta Company Information Table 83. Bioveta Introduction and Business Overview Table 84. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 85. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Offerings Table 86. Bioveta Recent Development Table 87. Jinyu Bio-Technology Company Information Table 88. Jinyu Bio-Technology Introduction and Business Overview Table 89. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 90. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Offerings Table 91. Jinyu Bio-Technology Recent Development Table 92. Zoetis Company Information Table 93. Zoetis Introduction and Business Overview Table 94. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 95. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Offerings Table 96. Zoetis Recent Development Table 97. Boehringer Ingelheim Company Information Table 98. Boehringer Ingelheim Introduction and Business Overview Table 99. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 100. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Offerings Table 101. Boehringer Ingelheim Recent Development Table 102. Harbin Pharmaceutical Group Company Information Table 103. Harbin Pharmaceutical Group Introduction and Business Overview Table 104. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 105. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Offerings Table 106. Harbin Pharmaceutical Group Recent Development Table 107. Key Raw Materials Lists Table 108. Raw Materials Key Suppliers Lists Table 109. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Downstream Customers Table 110. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors List Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Picture Figure 2. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million) Figure 3. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value (2019-2030) & (US$ Million) Figure 4. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume (2019-2030) & (K Units) Figure 5. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price (2019-2030) & (US$/Unit) Figure 6. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Report Years Considered Figure 7. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players Revenue Ranking (2023) & (US$ Million) Figure 8. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players Sales Volume Ranking (2023) & (K Units) Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue in 2023 Figure 10. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023 Figure 11. CH-1R Strain Picture Figure 12. PC Strain Picture Figure 13. Others Picture Figure 14. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million) Figure 15. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Market Share by Type, 2023 & 2030 Figure 16. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units) Figure 17. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume Market Share by Type, 2023 & 2030 Figure 18. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2019-2030) & (US$/Unit) Figure 19. Product Picture of Gilts Figure 20. Product Picture of Sows Figure 21. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million) Figure 22. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Market Share by Application, 2023 & 2030 Figure 23. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units) Figure 24. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume Market Share by Application, 2023 & 2030 Figure 25. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2019-2030) & (US$/Unit) Figure 26. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value (2019-2030) & (US$ Million) Figure 27. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Country (%), 2023 VS 2030 Figure 28. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value (2019-2030) & (US$ Million) Figure 29. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Country (%), 2023 VS 2030 Figure 30. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value (2019-2030) & (US$ Million) Figure 31. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Country (%), 2023 VS 2030 Figure 32. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value (2019-2030) & (US$ Million) Figure 33. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Country (%), 2023 VS 2030 Figure 34. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value (2019-2030) & (US$ Million) Figure 35. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Country (%), 2023 VS 2030 Figure 36. Key Countries/Regions PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value (%), (2019-2030) Figure 37. Key Countries/Regions PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume (%), (2019-2030) Figure 38. United States PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, (2019-2030) & (US$ Million) Figure 39. United States PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type (%), 2023 VS 2030 Figure 40. United States PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application (%), 2023 VS 2030 Figure 41. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, (2019-2030) & (US$ Million) Figure 42. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type (%), 2023 VS 2030 Figure 43. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application (%), 2023 VS 2030 Figure 44. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, (2019-2030) & (US$ Million) Figure 45. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type (%), 2023 VS 2030 Figure 46. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application (%), 2023 VS 2030 Figure 47. Japan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, (2019-2030) & (US$ Million) Figure 48. Japan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type (%), 2023 VS 2030 Figure 49. Japan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application (%), 2023 VS 2030 Figure 50. South Korea PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, (2019-2030) & (US$ Million) Figure 51. South Korea PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type (%), 2023 VS 2030 Figure 52. South Korea PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application (%), 2023 VS 2030 Figure 53. Southeast Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, (2019-2030) & (US$ Million) Figure 54. Southeast Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type (%), 2023 VS 2030 Figure 55. Southeast Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application (%), 2023 VS 2030 Figure 56. India PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value, (2019-2030) & (US$ Million) Figure 57. India PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type (%), 2023 VS 2030 Figure 58. India PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application (%), 2023 VS 2030 Figure 59. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industrial Chain Figure 60. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Cost Structure Figure 61. Channels of Distribution (Direct Sales, and Distribution) Figure 62. Bottom-up and Top-down Approaches for This Report Figure 63. Data Triangulation Figure 64. Key Executives Interviewed
